Breakthrough Chemistry (BKTH) Ratios
Breakthrough Chemistry Ratios
BKTH's free cash flow for Q4 2025 was $54.43K. For the 2025 fiscal year, BKTH's free cash flow was decreased by $-4.00 and operating cash flow was $54.43K. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 6.17 | 0.20 | 0.29 | 0.40 | 0.18 |
| Quick Ratio | 6.02 | 0.09 | 0.01 | 0.01 | 0.06 |
| Cash Ratio | 0.02 | 0.00 | 0.00 | 0.00 | 0.06 |
| Solvency Ratio | 3.59 | -0.00 | -0.41 | -0.45 | -0.53 |
| Operating Cash Flow Ratio | -0.04 | -0.15 | -0.23 | -0.25 | -0.27 |
| Short-Term Operating Cash Flow Coverage | -0.07 | -0.31 | -0.45 | -0.37 | -0.35 |
| Net Current Asset Value | $ 1.59M | $ -308.08K | $ -306.16K | $ -214.99K | $ -233.91K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.08 | 0.22 | 0.23 | 0.23 | 2.71 |
| Debt-to-Equity Ratio | 0.10 | 0.40 | 0.43 | 0.36 | -1.08 |
| Debt-to-Capital Ratio | 0.09 | 0.29 | 0.30 | 0.26 | 13.64 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.22 | 1.82 | 1.83 | 1.53 | -0.40 |
| Debt Service Coverage Ratio | -0.55 | -0.19 | -0.55 | -0.37 | -0.23 |
| Interest Coverage Ratio | -411.62 | -4.02 | -5.28 | -2.58 | -0.85 |
| Debt to Market Cap | 0.50 | 0.06 | 0.23 | 0.14 | 0.10 |
| Interest Debt Per Share | 0.02 | 0.02 | 0.03 | 0.04 | 0.04 |
| Net Debt to EBITDA | -1.75 | -4.69 | -1.57 | -2.22 | -2.94 |
| Profitability Margins | |||||
| Gross Profit Margin | -167.64% | -71.51% | -231.64% | -107.64% | 43.89% |
| EBIT Margin | -963.87% | -253.25% | -980.70% | -979.09% | -415.80% |
| EBITDA Margin | -711.17% | -120.53% | -743.17% | -795.55% | -415.80% |
| Operating Profit Margin | -963.87% | -253.25% | -980.70% | -979.09% | -415.80% |
| Pretax Profit Margin | 9569.50% | -138.41% | -1166.47% | -1354.03% | -905.77% |
| Net Profit Margin | 9569.50% | -138.41% | -1166.47% | -1354.03% | -905.77% |
| Continuous Operations Profit Margin | 9569.50% | -138.41% | -1166.47% | -1354.03% | -905.77% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | -992.82% | 54.66% | 118.94% | 138.30% | 217.84% |
| Return on Assets (ROA) | 61.83% | -5.44% | -23.15% | -17.89% | -185.94% |
| Return on Equity (ROE) | 75.13% | -9.88% | -42.46% | -27.31% | 74.11% |
| Return on Capital Employed (ROCE) | -7.23% | -18.08% | -35.70% | -19.75% | 34.02% |
| Return on Invested Capital (ROIC) | -6.59% | -12.87% | -25.01% | -14.55% | -430.13% |
| Return on Tangible Assets | 72.11% | -60.02% | -173.58% | -128.38% | -291.73% |
| Earnings Yield | 370.78% | -1.44% | -22.98% | -10.53% | -6.58% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 4.66 | 0.00 | 0.00 |
| Payables Turnover | 0.84 | 1.32 | 1.10 | 0.86 | 0.00 |
| Inventory Turnover | 0.82 | 1.40 | 0.51 | 0.20 | 0.27 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.01 | 0.04 | 0.02 | 0.01 | 0.21 |
| Working Capital Turnover Ratio | 0.02 | -0.11 | -0.07 | -0.06 | -0.11 |
| Cash Conversion Cycle | 9.60 | -15.47 | 456.22 | 1405.98 | 1368.61 |
| Days of Sales Outstanding | 0.00 | 0.00 | 78.35 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 443.09 | 260.81 | 710.45 | 1829.32 | 1368.61 |
| Days of Payables Outstanding | 433.49 | 276.27 | 332.57 | 423.34 | 0.00 |
| Operating Cycle | 443.09 | 260.81 | 788.79 | 1829.32 | 1368.61 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.00 | -0.01 | -0.01 | -0.01 | -0.01 |
| Free Cash Flow Per Share | -0.00 | -0.01 | -0.01 | -0.01 | -0.01 |
| Dividend Paid and CapEx Coverage Ratio | -4371.00 | -19601.00 | -32967.67 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | -4371.00 | -19601.00 | -32967.67 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | -0.07 | -0.31 | -0.45 | -0.37 | -0.35 |
| Operating Cash Flow to Sales Ratio | -0.87 | -1.74 | -5.23 | -6.56 | -4.58 |
| Free Cash Flow Yield | -3.37% | -1.81% | -10.30% | -5.11% | -3.33% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 0.27 | -69.69 | -4.35 | -9.50 | -15.20 |
| Price-to-Sales (P/S) Ratio | 25.81 | 96.40 | 50.76 | 128.58 | 137.66 |
| Price-to-Book (P/B) Ratio | 0.20 | 6.88 | 1.85 | 2.59 | -11.26 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -29.68 | -55.35 | -9.71 | -19.59 | -30.03 |
| Price-to-Operating Cash Flow Ratio | -29.67 | -55.34 | -9.71 | -19.59 | -30.03 |
| Price-to-Earnings Growth (PEG) Ratio | -0.00 | 0.88 | -0.81 | -0.49 | 0.15 |
| Enterprise Value Multiple | -5.38 | -84.67 | -8.40 | -18.38 | -36.05 |
| Enterprise Value | 576.50K | 3.45M | 1.18M | 2.02M | 2.51M |
| EV to EBITDA | -5.38 | -84.67 | -8.40 | -18.38 | -36.05 |
| EV to Sales | 38.24 | 102.05 | 62.45 | 146.21 | 149.90 |
| EV to Free Cash Flow | -43.97 | -58.59 | -11.94 | -22.27 | -32.71 |
| EV to Operating Cash Flow | -43.96 | -58.59 | -11.94 | -22.27 | -32.71 |
| Tangible Book Value Per Share | 0.16 | -0.03 | -0.03 | -0.03 | -0.03 |
| Shareholders’ Equity Per Share | 0.20 | 0.05 | 0.06 | 0.08 | -0.03 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | 0.15 | -0.00 | -0.02 | -0.02 | -0.02 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | -9.93 | 0.55 | 1.19 | 1.38 | 2.18 |
| Research & Development to Revenue | 0.28 | 0.04 | 0.28 | 0.00 | 0.00 |
| SG&A to Revenue | 7.69 | 1.78 | 7.21 | 8.71 | 4.60 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -0.01 | 1.26 | 0.45 | 0.48 | 0.51 |
Currency in USD
